{"id":195,"date":"2020-10-08T16:01:21","date_gmt":"2020-10-08T16:01:21","guid":{"rendered":"https:\/\/thenextweb.com\/?p=1322358"},"modified":"2020-10-08T16:01:21","modified_gmt":"2020-10-08T16:01:21","slug":"crisprs-nobel-prize-sent-gene-editing-stocks-into-overdrive","status":"publish","type":"post","link":"https:\/\/www.londonchiropracter.com\/?p=195","title":{"rendered":"CRISPR\u2019s Nobel Prize sent gene-editing stocks into overdrive"},"content":{"rendered":"\n

Biotech stocks continued to surge on Wednesday after two scientists responsible for gene-editing tool CRISPR received this year\u2019s Nobel Prize<\/a> for Chemistry.<\/p>\n

CRISPR-powered stocks Intellia Therapeutics (NTLA), Editas Medicine (EDIT), and Beam Therapeutics (BEAM) have now jumped 13%, 11%, and 6% respectively.<\/p>\n

CRISPR Therapeutics (CRSP), co-founded by one of the Nobel winners Emmanuelle Charpentier, <\/span>is also up more than 11% since Wednesday morning.<\/p>\n

<\/figure>\n<\/p>\n

Collectively, these four CRISPR stocks are now worth nearly $12.2 billion \u2014<\/span> up from $6.5 billion in February with nearly $430 million added to their market values overnight.<\/p>\n

Now valued beyond $7.1 billion, CRSP is by far the biggest CRISPR-centric company on the market. And it\u2019s the best performing of the four above, having returned 65% so far. Tennessee-headquartered NTLA is second with 63%.<\/p>\n

Wall Street rates CRISPR-powered stocks<\/h2>\n

CRISPR offers a relatively cheap and relatively method of editing practically any kind of DNA (animal or otherwise).<\/p>\n

As one might expect, it\u2019s already triggered a myriad of moral, ethical, and legal troubles for scientists, but researchers say the tool could lead to cures for a wide array of genetic diseases.<\/p>\n

[Read: Esports and gaming stocks are returning more profit than Bitcoin<\/a>]<\/em><\/p>\n

\"CRISPR,<\/figure>\n

For what it\u2019s worth, Bank of America (BoA) finds the hype justified, at least in the short-term. BoA analysts reportedly issued<\/a> their first rating to CRSP earlier this week: \u201cBuy\u201d with a price target of $110 (current price $96).<\/p>\n

Goldman Sachs also rated NTLA for the first time last month when it labelled it a \u201cBuy\u201d and set its price target to $33 (current price $23), according to finance portal Finviz<\/a>.<\/p>\n

None of this is investment advice. Don\u2019t pretend it is, because it\u2019s not. Always do your own research.<\/em><\/p>\n

Published October 8, 2020 \u2014 16:01 UTC <\/p>\n

Source<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Biotech stocks continued to surge on Wednesday after two scientists responsible for gene-editing tool CRISPR received this year\u2019s Nobel Prize for Chemistry. CRISPR-powered stocks Intellia Therapeutics (NTLA), Editas Medicine (EDIT), and Beam Therapeutics…<\/p>\n","protected":false},"author":1,"featured_media":196,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/www.londonchiropracter.com\/index.php?rest_route=\/wp\/v2\/posts\/195"}],"collection":[{"href":"https:\/\/www.londonchiropracter.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.londonchiropracter.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.londonchiropracter.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.londonchiropracter.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=195"}],"version-history":[{"count":0,"href":"https:\/\/www.londonchiropracter.com\/index.php?rest_route=\/wp\/v2\/posts\/195\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.londonchiropracter.com\/index.php?rest_route=\/wp\/v2\/media\/196"}],"wp:attachment":[{"href":"https:\/\/www.londonchiropracter.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=195"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.londonchiropracter.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=195"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.londonchiropracter.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=195"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}